Tag: TAS-120-101

Home / TAS-120-101

Categories

Cccelerated approval is granted by FDA to futibatinib for cholangiocarcinoma

November 2022: The Food and Drug Administration granted accelerated approval to futibatinib (Lytgobi, Taiho Oncology, Inc.) for adult patients with previously treated, unresectable, locally advanced o...
tas-120-101

We Are Online! Chat With Us!
Scan the code